Palliative Care 
 outpatient visits following discharge to home or residential aged care facilities (RACF)  outpatient clinic consultations.  to work within the Scope of Practice according to principles of best practice;  liaise with community providers and carers to allow patients to remain in their homes for end of life care  facilitate admission to SAH either via Emergency Care (EC) or as a direct admission to the Palliative Care Ward (POON), in collaboration with their AMO.
Target Population of service
The age range of patients will be eighteen years and over.
Health Service Setting
Adventist Healthcare Limited currently provides inpatient palliative care services. These services are not defined by LGA or NSW Local Health Districts. Patients are seen within the hospital with a small proportion of acute palliative care patients attending outpatient clinics. Patients are managed at home in collaboration with the local community services and their General Practitioner within an area of approximately 15km.
Facilities/Facility where the Nurse Practitioner Role or Service Operates
The PCNP covers the geographical area of the upper north shore and northwest of Sydney. The primary practice environment for the PCNP is Sydney Adventist Hospital. Patients will also be seen in their own homes and local aged care facilities within a ten kilometre radius of SAH.
Operational Aspects
The PCNP is employed by Adventist Healthcare Limited
Elements of care
Palliative Care refers to the care of any patients with a life limiting illness. Often these patients may be referred early in their illness trajectory for symptom control, education/ information or psychosocial issues and support. Once immediate issues are resolved the patient is followed up with telephone contact until they require further face to face intervention.
This includes but is not restricted to end stage:
Service Description

Parameters of practice
Malignancy; neurodegenerative disorders; dementia; renal disease; cardiovascular disease; chronic respiratory disease and AIDS related diseases. These disease processes can manifest a multitude of complex symptoms for patients. Exclusion from care  The PCNP will not see patients with chronic pain only.  Persons under the age of eighteen  Persons with chronic and complex care that is potentially reversible and not life limiting
Process of care
The assessment and management of individuals by the PCNP is aimed at managing symptoms, determining where the patient is in their illness trajectory and determining reversible and irreversible conditions. The process is guided by evidenced based practice. Referrals will be accepted by telephone -providing follow-up documentation is provided.
Prescribing and dispensing arrangements
 The PCNP formulary lists the poisons and restricted substances that may be processed, used, supplied or prescribed by the nurse practitioner under Section 17a of the Poisons and Therapeutic Goods Act 1966 (2) & Part 1 section 4 & 4A of the Poisons Therapeutic Goods Regulation 2008 (3).  The PCNP is allocated a Prescriber Number and may prescribe items included on the PBS schedule as NP items and private prescriptions for patients in the community.  The PCNP can prescribe medications on an inpatient medication chart.  The PCNP has the authority to initiate, cease and titrate those medications listed in the PCNP Formulary.  Medications will only be prescribed following assessment of the individual patient.  The principles of the Quality Use of Medicines are observed  The PCNP will use the most recent Australian Medicines Handbook; MIMS or MIMS 'online'; and Therapeutic Guidelines: Palliative Care.  The PCNP will document, maintain and update medical records for all medication changes made by the PCNP. The PCNP will observe, record, report patient's condition, efficacy and reaction to drugs and treatment to the relevant health professionals.  The PCNP will consult with the GP / Medical Specialist / Palliative Care Specialist, when appropriate, to discuss management plans for complex patients and for those patients not responding as expected to recommendations.  Many medications used in Palliative Care are used 'off label', for indications, and routes of administration outside of the TGA approval. These indications and routes of administration are evidenced based in the Palliative Care literature.  The PCNP can cease drugs no longer required after discussion with the patient and family and at the request of the General Practitioner or Medical Specialist.  Patients in the terminal phase of their illness will have reduced ability or inability to swallow medications. The PCNP will reduce or cease oral medications and change to an alternate route, as appropriate. This process is undertaken in an informative collaborative manner with the patient, family and carers as well as their attending medical practitioner.
Diagnostic investigation arrangements
Investigations are required to assist diagnosis or provide a baseline of health. The PCNP may order appropriate medical imaging and pathology investigations if there will be a clear benefit to symptom management and patient outcome. Appropriate investigations may include but are not limited to:
 Urine culture and sensitivity  Sputum culture and sensitivity  Wound swabs culture and sensitivity  Pathology: including FBC; Group & hold cross match; LFT; Calcium (corrected); UEC; INR; APPT.  Medical Imaging: Plain X-rays -including chest, abdomen, skeletal  Other diagnostic investigations may be ordered following discussion with the referring team.
It is the responsibility of the PCNP to ensure that these results are followed up, interpreted and documented in a timely manner and to consult appropriately with the referring team to discuss management or follow up with the AMO, if required.
If the PCNP is away on leave arrangements will be made for the follow up of any investigations ordered.
The PCNP has a commitment to prevent duplication of services and unnecessary diagnostic investigations and consultation with pathology and medical imaging staff should occur as appropriate.
Appended Formulary YES NO
Exclusions: A nurse practitioner must not prescribe, give a written or oral instruction or supply or administer medicines (1) that have not been approved by the Therapeutic Goods Administration outside the terms of the manufacturer's product information (off-label) unless sufficient evidence to demonstrate safety.
Specific procedural activities
Including but not limited to:  Management of Peritoneal implantable ports. This includes accessing, drainage of acities fluid as prescribed by Specialist team and heparin locking as per SAH policy and procedure manual.  Management of venous implantable port. This includes accessing and heparin locking as per SAH policy and procedure manual.
 Monitoring of Blood Glucose Levels (BGL
Collaborative arrangements
Collaborative arrangements are required to enable Nurse Practitioners to provide access for patients to MBS and PBS subsidy. Arrangements are in line with s5(1a) of the National Health (collaborative arrangements for nurse practitioners) Determination 2010. The PCNP complies with these requirements by:
 Where a patient is referred in writing to an eligible nurse practitioner by a specified medical practitioner; or,  An oral arrangement exists between the nurse practitioner and a specified medical practitioner and the nurse practitioner documents a series of prescriptive notes in the clinical record.
The PCNP will consult appropriately according to the patient's Palliative Care Outcomes Collaborative (PCOC) phase, where the patient is in their illness trajectory and the agreed management plan for the patient:
 Persistent signs or symptoms beyond the expected time of resolution despite treatment;  Sign(s) of recurrent or persistent infection;  Any atypical presentation of a common illness or unusual response to treatment;  Any sign(s) or symptom(s) of behavioural changes that cannot be attributed to a specific organic cause;  Palliative Care emergencies such as cord compression, hypocalcaemia, superior vena cava obstruction;  Symptomatic or laboratory evidence of previously unidentified change in condition or unexpected deteriorating function of any vital organ or system;  When a patient's condition destabilises unexpectedly;  When it is determined by the PCNP after assessment, be it ongoing or emergency, that the treatment or diagnostic test needs fall outside the approved Scope of Practice;  When a patient requires admission;  Any other conditions or patients who are outside the approved Scope of Practice.
A therapeutic management plan will be formulated by the PCNP in line with best practice. Consent will be obtained from patients prior to consultation and Scope of Practice and Drug Formulary will be made available to other health professionals within multidisciplinary team.
Study, clinical supervision and mentorship arrangements
The PCNP is responsible for the maintenance of their clinical knowledge and skills through ongoing professional development. This includes but is not limited to: In addition, the PCNP will comply with all applicable SAH and NSW Health policies, procedures and guidelines.
Clinical Governance Arrangements
In an emergency situation the PCNP will be expected to do no harm, and to act in the best interests of the patient.
The PCNP will participate in the continuing evaluation of the Palliative Care service.
The PCNP will have access to but is not limited to:
 
Clinical Resources Professional role activities Nurse Practitioner SAH
Strategy for evaluation of model and ScOP review
Patient and health professional surveys will be used to evaluate the PCNP services. Information gathered by these surveys will help direct goal setting and improve service provision.
The PCNP and Nursing Services /committee shall update, evaluate and amend the scope of practice whenever the PCNP's duties have substantively changed or every twelve months when the service requirements are reviewed, incorporating the annual performance appraisal.
Any alterations must be submitted to the Chief Executive of Adventist Healthcare Limited. This document is invalid if any alterations or amendments are made without the approval from the Chief Executive of Adventist Healthcare Limited.
Performance review
Regular meetings with the Nursing Unit Manager POON ward will be undertaken to ensure compliance, give support and mentor the PCNP. 
Multidisciplinary Support
The Multidisciplinary Support agree that this scope of practice and model has been developed collaboratively and is supported practice for the named nurse practitioner. 
Position
